Nrf2 is suppressed in FA patients and therefore suppresses mitochondrial function and diminishes antioxidant levels due to a genetic mutation in frataxin, a protein involved in iron homeostasis. The gene discussed is NFE2L2; the disease is Friedreich ataxia.